We are thrilled to announce that the declaration of conformity for the ResiScreen® Staph kit under Regulation (EU) 2017/746 (IVDR) has been signed.
Our CE-marked test is now fully ready for commercialization across Europe through our partnership with Eurobio Scientific.
Leveraging our patented SmartID® fluorescent biotracer technology, ResiScreen® Staph is currently the only reliable phenotypic test to detect penicillinase BlaZ activity in Staphylococcus aureus and coagulase-negative staphylococci.
This achievement reflects the dedication, expertise, and collaboration of the entire Molsid team and our partners: another step forward in improving antimicrobial resistance detection.
Recent posts
It was a pleasure for MOLSID, represented by its Executive Director Younes Lazrak, to present our product pipeline at this year’s ESCMID GLOBAL. Many thanks
A new fundraising round has been opened and will close in Q1 2024, with existing and new investors. This round will allow us to speed
We have updated our corporate clip. Have a look to learn more about who we are and what we do!
